279 related articles for article (PubMed ID: 17498528)
1. Breast cancer risk assessment and risk reduction.
Newman LA; Vogel VG
Surg Clin North Am; 2007 Apr; 87(2):307-16, vii-viii. PubMed ID: 17498528
[TBL] [Abstract][Full Text] [Related]
2. Risk-reducing strategies for breast cancer--a review of recent literature.
Mokbel K
Int J Fertil Womens Med; 2003; 48(6):274-7. PubMed ID: 15646397
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of breast cancer for women at high risk.
Chan K; Morris GJ
Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention Indication Score: a user-friendly tool for prevention of breast cancer - pilot analysis.
Layeequr Rahman R; Crawford S
Breast; 2009 Oct; 18(5):289-93. PubMed ID: 19716702
[TBL] [Abstract][Full Text] [Related]
5. Reducing the risk of breast cancer with tamoxifen in women at increased risk.
Vogel VG
J Clin Oncol; 2001 Sep; 19(18 Suppl):87S-92S. PubMed ID: 11560980
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
Crowell EB; Jubelirer SJ
W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
[TBL] [Abstract][Full Text] [Related]
7. Prevention of breast cancer (Part II): risk reduction strategies.
Tirona MT; Sehgal R; Ballester O
Cancer Invest; 2010 Dec; 28(10):1070-7. PubMed ID: 20932221
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention in postmenopausal women.
Rastogi P
Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
[TBL] [Abstract][Full Text] [Related]
9. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
10. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
11. Prescription of tamoxifen for breast cancer prevention by primary care physicians.
Armstrong K; Quistberg DA; Micco E; Domchek S; Guerra C
Arch Intern Med; 2006 Nov; 166(20):2260-5. PubMed ID: 17101945
[TBL] [Abstract][Full Text] [Related]
12. A review of breast cancer chemoprevention.
Chang JC
Biomed Pharmacother; 1998; 52(3):133-6. PubMed ID: 9755806
[TBL] [Abstract][Full Text] [Related]
13. The current status of breast cancer chemoprevention: a star is born.
Morrow M; Jordan VC
J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883
[No Abstract] [Full Text] [Related]
14. Women at high risk for breast cancer: preventive strategies.
Sakorafas GH
Mt Sinai J Med; 2002 Sep; 69(4):264-6. PubMed ID: 12357269
[TBL] [Abstract][Full Text] [Related]
15. DM effort seeks to improve outcomes through prevention, early detection of breast cancer.
Dis Manag Advis; 2000 Sep; 6(9):140-4, 132. PubMed ID: 11125466
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of breast cancer.
Castrellon AB; Glück S
Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
[TBL] [Abstract][Full Text] [Related]
17. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB
J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen (TAM): the dispute goes on.
Grilli S
Ann Ist Super Sanita; 2006; 42(2):170-3. PubMed ID: 17033137
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk in primary care: implications for chemoprevention.
Lewis CL; Kinsinger LS; Harris RP; Schwartz RJ
Arch Intern Med; 2004 Sep; 164(17):1897-903. PubMed ID: 15451765
[TBL] [Abstract][Full Text] [Related]
20. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]